We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Places Clinical Hold on Geron’s Investigational Cancer Candidate
FDA Places Clinical Hold on Geron’s Investigational Cancer Candidate
The FDA has placed clinical trials for California-based biotech Geron’s blood cancer candidate, imetelstat, on hold after liver abnormalities were found in study subjects.